# Brown Biotech Daily Tech Digest — 2026-08-22 > 매일 아침 AI·바이오텍·펩타이드 시장 시그널을 수집하고, > Brown Biotech 파이프라인 관점에서 decision-ready 인사이트로 정리합니다. ## 🔬 Today's Top Signals ### 1. GLP-1 drugs linked to bigger jump in women's employment than a degree **Source:** Yahoo Finance · **Score:** 4/8 GLP-1 economic-drug category, validates CDMO demand surge. ### 2. Online clinics and influencers are promoting Cialis as a longevity drug **Source:** NPR · **Score:** 4/8 Telehealth off-label longevity confirms gray-market peptide demand. ### 3. AI in drug discovery – what it is, where we stand and the path forward **Source:** Science.org · **Score:** 3/8 AI drug-discovery real but uneven, validates biostatx pitch. ### 4. FDA staff and peptide enthusiasts set to clash at advisory panel **Source:** STAT News · **Score:** 4/8 Compounding-pharmacy regulation shift, CDMO demand rises. ### 5. Launch HN: Discovered Materials (YC P26) – AI agents to discover new materials **Source:** HN Algolia · **Score:** 3/8 YC P26 specialist AI-agents-for-materials validates biostatx agent thesis. ## 💡 Brown Biotech Insights - *peptide-service*: GLP-1 + longevity demand = dual CDMO tailwinds. - *biostatx*: AI drug-discovery + Discovered Materials = specialist-agent thesis validated. - *business-pipeline*: FDA peptide panel = regulatory tailwind, prep CDMO outreach. - Sourcing: HN Algolia 7d+30d; Reddit ML/bio + GeekNews blocked. ## 🎯 Next Action Draft Q3 GLP-1 CDMO outreach citing Harvard employment study for peptide-service positioning. --- _Published 2026-08-22 07:05 KST · [brownbio.tech](https://brownbio.tech) · Source: Hacker News, GeekNews, Reddit ML/bioinformatics, Science Immunology_
2026-08-22